January 28, 2026
Adobe

STAT+ | Why some hospitals are making their own ChatGPTs for patient records

Some large health systems, including Stanford Health Care and Penn Medicine, are building AI-powered chatbots that help clinicians query patients' health records.

By Brittany Trang


15 new drugs added to Medicare price negotiations

Third round of CMS drug price negotiations target 15 drugs, including Trulicity, Rexulti, Biktarvy, Xolair and Cosentyx. Prices would take effect in 2028.

By John Wilkerson


STAT+ | FDA halts gene therapy trials after brain tumor found in patient

The treatments are designed to replace the genes broken in mucopolysaccharidosis type I and type II, also known as Hurler and Hunter syndromes.

By Jason Mast



How ‘gas station drugs’ remain legal

This week’s STATus Report digs into how and why gas stations became the perfect marketplace for quasi-legal "gas station drugs."

By Alex Hogan


STAT+ | Trump administration signals there’s widespread desire to curb Medicare Advantage

Tiny pay raise and new risk adjustment rules for Medicare Advantage insurers signal Trump administration openness to go after abusive practices.

By Bob Herman


STAT+ | AI biotech founded by ex-Google CEO Eric Schmidt is raising $150 million

Hologen, a secretive AI startup co-founded by former Google CEO Eric Schmidt, is looking to raise $150 million in a Series A fundraising round. 

By Brittany Trang


Mario Tama/Getty Images

Opinion: Dogs might be the secret to getting some anxious patients in the dentist’s chair

Dentists in the trained therapy dog study reported calmer patients and smoother procedures. Psychologists attribute it to the "biophilia effect."

By Henry I. Miller


STAT+ | Opinion: Medicare may start covering multi-cancer early detection tests. It should proceed with caution

It’s not likely that multi-cancer early detection tests are the innovation we need to reduce cancer mortality — at least not yet.

By Barbara Levy and Badrinath Konety


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.